{"transactions":[{"id":2027854,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-07T23:15:20.000Z","date":"2023-02-01","kind":"tax_withholding","acquired":false,"shares":11904,"price":8.2,"value":97612.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\") on February 1, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":859075,"source":{"system":"sec-edgar","filing":"0001828318-23-000031","document":"wf-form4_167581169723724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000182831823000031/wf-form4_167581169723724.xml","form_type":"4"}},{"id":2125030,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-11-04T00:09:21.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":30000,"price":18.55,"value":556500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.26 to $19.24, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 59,656 shares issuable on the settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuers' common stock."}],"balance_after":899565,"source":{"system":"sec-edgar","filing":"0001828318-22-000064","document":"wf-form4_166752054502983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000182831822000064/wf-form4_166752054502983.xml","form_type":"4"}},{"id":2141757,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-10-05T20:38:04.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":3802,"price":18.52,"value":70413.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.47 to $18.59, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 59,656 shares issuable on the settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuers' common stock."}],"balance_after":929565,"source":{"system":"sec-edgar","filing":"0001828318-22-000047","document":"wf-form4_166500226352417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000182831822000047/wf-form4_166500226352417.xml","form_type":"4"}},{"id":2141756,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-10-05T20:38:04.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":26198,"price":17.96,"value":470516.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.47 to $18.465, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 59,656 shares issuable on the settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuers' common stock."}],"balance_after":933367,"source":{"system":"sec-edgar","filing":"0001828318-22-000047","document":"wf-form4_166500226352417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000182831822000047/wf-form4_166500226352417.xml","form_type":"4"}},{"id":2167029,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-09-02T21:22:07.000Z","date":"2022-09-01","kind":"sale","acquired":false,"shares":30000,"price":20.67,"value":620100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.31 to $21.39, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 59,656 shares issuable on the settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuers' common stock."}],"balance_after":959565,"source":{"system":"sec-edgar","filing":"0001828318-22-000037","document":"wf-form4_166215370382955.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000182831822000037/wf-form4_166215370382955.xml","form_type":"4"}},{"id":2186484,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-12T21:45:01.000Z","date":"2022-08-11","kind":"sale","acquired":false,"shares":10000,"price":20,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 59,656 shares issuable on the settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuers' common stock."}],"balance_after":989565,"source":{"system":"sec-edgar","filing":"0001828318-22-000021","document":"wf-form4_166034068514755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000182831822000021/wf-form4_166034068514755.xml","form_type":"4"}},{"id":2192836,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-06T00:44:54.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":50000,"price":14,"value":700000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $14.00 to $14.01, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 59,656 shares issuable on the settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuers' common stock."}],"balance_after":999565,"source":{"system":"sec-edgar","filing":"0001828318-22-000007","document":"wf-form4_165974667389005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000182831822000007/wf-form4_165974667389005.xml","form_type":"4"}},{"id":2238573,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-06-09T00:20:20.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":59656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares issuable on the settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on the first anniversary of the date of grant (the \"Vesting Commencement Date\"); and the remainder will vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":1049565,"source":{"system":"sec-edgar","filing":"0001209191-22-035256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000120919122035256/doc4.xml","form_type":"4"}},{"id":2238570,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-06-09T00:12:33.000Z","date":"2022-05-20","kind":"tax_withholding","acquired":false,"shares":908,"price":9.31,"value":8453.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 24,2022, the Reporting Person filed a Form 4 which inadvertently neglected to report the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the fully vested award of 2,214 restricted stock units on May 20, 2022.  Each restricted stock unit represented the right to received one share of the Issuer's common stock."}],"balance_after":989909,"source":{"system":"sec-edgar","filing":"0001209191-22-035250","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000120919122035250/doc4a.xml","form_type":"4/A","original_submission_date":"2022-05-24"}},{"id":2257642,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-05-24T23:36:23.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":2214,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received a fully vested award of 2,214 restricted stock units on May 20, 2022.  Each restricted stock unit represents a right to receive one share of the Issuer's common stock."}],"balance_after":990817,"source":{"system":"sec-edgar","filing":"0001209191-22-031752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000120919122031752/doc4.xml","form_type":"4"}},{"id":2320708,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-22T21:27:00.000Z","date":"2022-03-18","kind":"grant","acquired":true,"shares":3939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested on the date of grant."}],"balance_after":3939,"derivative":{"exercise_price":15.47,"expiration_date":"2032-03-17","underlying":"Common Stock","underlying_shares":3939},"source":{"system":"sec-edgar","filing":"0001209191-22-020579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000120919122020579/doc4.xml","form_type":"4"}},{"id":2631528,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-17T00:57:56.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":110176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation (\"RSVAC\"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC (\"Merger Sub\"), and Enovix Corporation, a Delaware corporation (\"Legacy Enovix\"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in exchange for a stock option to purchase 596,800 shares of Legacy Enovix Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are immediately exercisable.  1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":110176,"derivative":{"exercise_price":9.2626,"expiration_date":"2031-04-19","underlying":"Common Stock","underlying_shares":110176},"source":{"system":"sec-edgar","filing":"0001209191-21-047044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000120919121047044/doc4.xml","form_type":"4"}},{"id":2631527,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-17T00:57:56.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":13845,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation (\"RSVAC\"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC (\"Merger Sub\"), and Enovix Corporation, a Delaware corporation (\"Legacy Enovix\"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in exchange for a stock option to purchase 75,000 shares of Legacy Enovix Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in 48 equal monthly installments beginning on the vesting commencement date, September 1, 2017, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":13845,"derivative":{"exercise_price":0.0498,"expiration_date":"2027-12-13","underlying":"Common Stock","underlying_shares":13845},"source":{"system":"sec-edgar","filing":"0001209191-21-047044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000120919121047044/doc4.xml","form_type":"4"}},{"id":2631526,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":117167,"kind":"person","name":"Dales Gardner Cameron","position":1,"cik":"0001868718","reported_name":"Dales Gardner Cameron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-07-17T00:57:56.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":988603,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation (\"RSVAC\"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC (\"Merger Sub\"), and Enovix Corporation, a Delaware corporation (\"Legacy Enovix\"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation (\"RSVAC\"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC (\"Merger Sub\"), and Enovix Corporation, a Delaware corporation (\"Legacy Enovix\"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation."}],"balance_after":988603,"source":{"system":"sec-edgar","filing":"0001209191-21-047044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828318/000120919121047044/doc4.xml","form_type":"4"}}]}